Olga Goloubeva

1.7k total citations
27 papers, 1.3k citations indexed

About

Olga Goloubeva is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Olga Goloubeva has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Oncology. Recurrent topics in Olga Goloubeva's work include Estrogen and related hormone effects (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Immunotherapy and Immune Responses (4 papers). Olga Goloubeva is often cited by papers focused on Estrogen and related hormone effects (10 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Immunotherapy and Immune Responses (4 papers). Olga Goloubeva collaborates with scholars based in United States, Myanmar and Denmark. Olga Goloubeva's co-authors include Angela Brodie, Gauri Sabnis, Donna Neuberg, Luciana F. Macedo, Danijela Jelovac, Nicholas Mitsiades, Teru Hideshima, Nikhil C. Munshi, Constantine Mitsiades and Paul G. Richardson and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Olga Goloubeva

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Olga Goloubeva

Since Specialization

Citations

This map shows the geographic impact of Olga Goloubeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Goloubeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Goloubeva more than expected).

Fields of papers citing papers by Olga Goloubeva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Goloubeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Goloubeva. The network helps show where Olga Goloubeva may publish in the future.

Co-authorship network of co-authors of Olga Goloubeva

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Goloubeva. A scholar is included among the top collaborators of Olga Goloubeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Goloubeva. Olga Goloubeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Draft Genome Sequence of Pseudomonas aeruginosa Strain PA14-UM 2020 ·Microbiology Resource Announcements ·Vincent T. Lee, Reza Ghodssi, Najib M. El-Sayed, Rena D. Malik, Olga Goloubeva, Tracy H. Hazen, David A. Rasko	1
2	ReCAP: Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional Study 2016 ·Journal of Oncology Practice ·Eberechukwu Onukwugha, Nicholas J. Petrelli, Kathleen M. Castro, James F. Gardner, Jinani Jayasekera, Olga Goloubeva, (unknown), Erica J. McNamara, (unknown), (unknown), James D. Bearden, (unknown), (unknown), Irene Prabhu Das, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	20
3	Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer 2015 ·Breast Cancer Research and Treatment ·(unknown), Preeti Shah, (unknown), Gauri Sabnis, Olga Goloubeva, (unknown), Armina A. Kazi, Saranya Chumsri, Angela Brodie	10
4	A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) 2014 ·Cancer Immunology Immunotherapy ·Dan P. Zandberg, Sandra Rollins, Olga Goloubeva, Robert E. Morales, Ming Tan, R. Taylor, Jeffrey S. Wolf, Lisa M. Schumaker, Kevin J. Cullen, Ann B. Zimrin, Robert A. Ord, Joshua E. Lubek, Mohan Suntharalingam, John C. Papadimitriou, Dean L. Mann, Scott E. Strome, Martin J. Edelman	58
5	Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole 2011 ·Cancer Research ·Gauri Sabnis, Olga Goloubeva, Saranya Chumsri, Nguyen Nguyen, Saraswati Sukumar, Angela Brodie	126
6	High-Dose Spatially Fractionated GRID Radiation Therapy (SFGRT): A Comparison of Treatment Outcomes With Cerrobend vs. MLC SFGRT 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Geoffrey Neuner, Majid Mohiuddin, (unknown), Olga Goloubeva, (unknown), C Yu, William F. Regine	92
7	Computer assisted quantitative immunofluorescence of tumor tissue marker expression and clinical outcome to chemotherapy in advanced breast cancer patients. 2011 ·PubMed ·Katherine H. R. Tkaczuk, Nancy Tait, Olga B. Ioffe, Ming Tan, Olga Goloubeva, Stephen A. Lesko, (unknown), (unknown), (unknown), (unknown), David Van Echo, Paul O. P. Ts’o	3
8	Stopping Treatment Can Reverse Acquired Resistance to Letrozole 2008 ·Cancer Research ·Gauri Sabnis, Luciana F. Macedo, Olga Goloubeva, Adam Schayowitz, Angela Brodie	43
9	Combination of Anastrozole with Fulvestrant in the Intratumoral Aromatase Xenograft Model 2008 ·Cancer Research ·Luciana F. Macedo, Gauri Sabnis, Olga Goloubeva, Angela Brodie	65
10	Toremifene–atamestane; alone or in combination: Predictions from the preclinical intratumoral aromatase model 2007 ·The Journal of Steroid Biochemistry and Molecular Biology ·Gauri Sabnis, Luciana F. Macedo, Olga Goloubeva, Adam Schayowitz, Yue Zhu, Angela Brodie	6
11	Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer 2006 ·British Journal of Cancer ·Jesper B. Andersen, Mads Aaboe, Ernest C. Borden, Olga Goloubeva, Bret A. Hassel, Torben F. Ørntoft	71
12	Mitochondrial DNA Content Increase in Response to Cigarette Smoking 2006 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Elizabeth Mambo, Rodney J. Taylor, Olga Goloubeva, Shaoyu Zhou, Yoram Cohen, Khalid M. Minhas, Wayne M. Koch, James J. Sciubba, Anthony J. Alberg, David Sidransky, Joseph A. Califano	81
13	Germinal Center Function in the Spleen during Simian HIV Infection in Rhesus Monkeys 2006 ·The Journal of Immunology ·David Margolin, Erika F.H. Saunders, (unknown), Nicole de Rosa, Michael K. Axthelm, Olga Goloubeva, (unknown), Rebecca Gelman, Norman L. Letvin	15
14	Model systems: Mechanisms involved in the loss of sensitivity to letrozole 2005 ·The Journal of Steroid Biochemistry and Molecular Biology ·Angela Brodie, Danijela Jelovac, Gauri Sabnis, Brian J. Long, Luciana F. Macedo, Olga Goloubeva	35
15	Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: A study of the Eastern Cooperative Oncology Group (E1993) 2004 ·Leukemia & lymphoma ·Janice P. Dutcher, Sandra Lee, Robert J. Gallagher, Adel Makary, John Hines, (unknown), John P. Farnen, John M. Bennett, Elisabeth Paietta, Jacob M. Rowe, Olga Goloubeva, Peter H. Wiernik	7
16	Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model 2004 ·JNCI Journal of the National Cancer Institute ·Brian J. Long, Danijela Jelovac, Venkatesh Handratta, Apinya Thiantanawat, Nicol Macpherson, Joseph Ragaz, Olga Goloubeva, Angela Brodie	102
17	A surrogate marker profile for PML/RARα expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes 2004 ·Cytometry Part B Clinical Cytometry ·Elisabeth Paietta, Olga Goloubeva, Donna Neuberg, John M. Bennett, RE Gallagher, Janis Racevskis, G Dewald, Peter H. Wiernik, Martin S. Tallman	54
18	Interleukin‐12 and interleukin‐2‐induced invariant natural killer T‐cell cytokine secretion and perforin expression independent of T‐cell receptor activation 2003 ·Immunology ·Runhua Hou, Olga Goloubeva, Donna Neuberg, Jack L. Strominger, S. Brian Wilson	23
19	The Cyclin-Dependent Kinase Inhibitors p19Ink4d and p27Kip1 Are Coexpressed in Select Retinal Cells and Act Cooperatively to Control Cell Cycle Exit 2002 ·Molecular and Cellular Neuroscience ·Justine J. Cunningham, Edward M. Levine, Frédérique Zindy, Olga Goloubeva, Martine F. Roussel, Richard J. Smeyne	64
20	Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model. 2002 ·PubMed ·Richard LeBlanc, Laurence Catley, Teru Hideshima, Suzanne Lentzsch, Constantine Mitsiades, Nicholas Mitsiades, Donna Neuberg, Olga Goloubeva, Christine Pien, Julian Adams, Deepak Gupta, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson	372

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact